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Several lysosomal enzymes solubilized at pH 4 frqm saponin-treated membranes showed markedly variable 
affinities to the bovine liver phosphomannosyl receptor in both bovine and human livers. The enzymes from 
I-cell disease liver did not bind the receptor in spite of normal intracellular activities. N-Acetyl-/I-glucos- 
aminidase was effectively released from the membrane preparation of a control liver by mannose 6-phos- 
phate, and other sugars showed little effect in this experiment. However, in the I-cell disease liver, dis- 
sociation occurred not by mannose 6-phosphate but by other sugars, such as fucose, mannose and N-acetyl- 
D-glucosamine. These results indicate the presence of an alternate transport system other than the pathway 
mediated by the mannose 6-phosphate receptor, and the role of other sugar-binding proteins is discussed 
in intracellular processing and transport of newly synthesized enzymes. 
Phosphomannosyl receptor Lysosomal enzyme IntracelIular transport Alternate pathway I-cell disease 
1. INTRODUCTION 
Lysosomal enzymes are glycoproteins with high 
mannose type oligosaccharides in their molecules. 
Mannose 6-phosphate has been found in these 
sugar chains and characterized as a specific 
recognition marker of these enzymes in mam- 
malian cells. Recent studies revealed that the 
phosphomannosyl receptor (PMR) binds and 
transports enzyme molecules to lysosomes [I]. 
PMR was purified from some mammalian tissues 
[2-61. However, in previous studies the binding ac- 
tivity was investigated on soluble ‘high-uptake’ en- 
zymes obtained from materials different from 
those for preparation of the receptor [2-51. The in 
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vivo process of binding and transport of enzymes 
is not yet clear. 
Recently the mouse P338D1 macrophage was 
found to show high levels of intracellular acid 
hydrolase activities in spite of deficient PMR [7]. 
Furthermore, activities of lysosomal enzymes were 
normal in tissues of I-cell disease, a human disease 
caused by a defect in phosphorylation of these en- 
zyme molecules [8,9]. These results suggested the 
presence of an alternate pathway for the in- 
tracellular transport of lysosomal enzymes other 
than the PMR system. 
We report here different patterns in the binding 
of several ysosomal enzymes in hepatic membrane 
preparations to the bovine liver PMR. Among 
those, the pattern in the dissociation of the 
membrane-bound iV-acetyl-fl-glucosaminidase in- 
duced by various sugars showed definite changes in 
I-cell disease. 
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2. MATERIALS AND METHODS 0.025% NaNs, pH 7.5) or 50~1 of 60 mM mannose 
6-phosphate in the same buffer. 
2.1. Tissues 
Bovine liver tissues obtained from a 
slaughterhouse were kept frozen at - 7O”C, and 
human liver autopsy specimens were kept frozen at 
- 70°C (control) or -20°C (control and I-cell 
disease) until use. The diagnosis of I-cell disease 
was established in a 2-month-old boy who 
presented with severe somatic dysmorphism, 
typical inclusion bodies in fibroblasts and changes 
in intracellular and extracellular activities of 
lysosomal enzymes. 
2.5. Assays 
Enzyme activities were determined using 4-methyl- 
umbelliferyl glycosides (Nakarai) as substrates at 
37°C in 60~1 of 0.2 M citrate/O.2 M NaCl (pH 
4.5). Reactions were stopped by addition of 0.7 ml 
of 0.5 M glycine carbonate, pH 10.5. One unit of 
activity was defined as 1 nmol 4-methylumbelli- 
ferone liberated per h. Protein was determined by 
the method of Lowry et al. [ 111. 
2.2. Purification of bovine liver PMR and 
3. RESULTS 
preparation of anti-PMR antibody 3.1. Binding of ASE to immobilized bovine liver 
PMR was extracted and purified from fresh 
bovine liver membranes, and the anti-PMR an- 
tibody was prepared and purified as described [lo]. 
PMR 
2.3. Preparation of acid-soluble enzymes (ASE) 
from the saponin-treated total membrane 
fraction 
The liver homogenate was prepared in 50 mM 
Tris-HCl (pH 7.0) containing 0.25 M sucrose (1 g 
in 10 ml) with a Potter-Elvehjem type 
homogenizer at 900 rpm (5 strokes) twice at 4°C. 
The homogenate was centrifuged at 8OOxg for 
5 min and the supernatant at 105 000 x g for 1 h. 
The precipitate (TMF) was suspended in 8 ml of 50 
mM citrate-phosphate buffer (pH 7.0) containing 
0.25 M sucrose and 0.5% saponin (CPSS buffer), 
and then incubated at 4°C for 30 min. The suspen- 
sion was centrifuged and the precipitate (saponin- 
treated TMF) washed repeatedly in CPSS buffer 
until no further decrease in enzyme activities was 
observed in the supernatant. Finally the precipitate 
was suspended in 8 ml CPSS buffer (pH 4.0), and 
incubated at 4°C. After 30 min the suspension was 
centrifuged and the supernatant (ASE fraction) 
stored at -20°C. 
The rate of binding was calculated from the 
amounts of added and bound ASE, and is sum- 
marized in fig.1. In bovine liver, the majority 
(about 80%) of a-mannosidase and p- 
glucuronidase activities was found to bind the 
PMR, while binding occurred in less than 10% of 
a-glucosidase and a-galactosidase activities, and 
no significant binding was found in P-glucosidase 
activity. Other enzymes showed intermediate rates 
of binding. In the human liver frozen at -70°C 
for 7 months, measurable activities of N-acetyl-fl- 
glucosaminidase, ,&-glucuronidase and a- 
glucosidase were detected in the ASE fraction. The 
rates of binding in these human enzymes were 
similar to those in bovine enzymes: p- 
glucuronidase, 80%; N-acetyl-P-glucosaminidase, 
50%; a-glucosidase, 2%. Almost identical results 
were also demonstrated in another control 
specimen frozen at - 20°C for several years. How- 
ever, ,&glucuronidase and N-acetyl-fl-glucosamini- 
dase in the ASE fraction of the liver from a patient 
with I-cell disease did not bind PMR although ac- 
tivities of these enzymes were normal. 
2.4. Preparation of immobilized PMR 
3.2. Release of membrane-bound enzymes by 
various sugars 
PMR (0.5 pg) and anti-PMR antibody (3 pg) in 
30 ~1 PBS (20 mM potassium phosphate, 0.15 M 
NaCl, 0.02% NaNj, pH 7.2) were mixed with 20~1 
of 20% (v/v) IgG Sorb (Enzyme Center). The mix- 
ture was incubated at 37°C for 20 min, and then 
added to 50~1 Tris buffer (50 mM Tris, 0.05% 
Triton X-100, 0.15 M NaCl, 5 mM NaH2P04, 
Mannose 6-phosphate (10 mM) was most effec- 
tive for dissociation of lysosomal enzymes from 
the saponin-treated TMF in the bovine liver; 70% 
of the activity in the ASE fraction was released for 
P-glucuronidase, 27% for a-glucosidase, 60% for 
,&galactosidase, 43% for N-acetyl-fl-glucosamini- 
dase, 50% for a-fucosidase, and 90% for cy- 
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natant. The amount of each enzyme bound to im- 
mobilized PMR in the presence of mannose 6-phosphate 
was subtracted from that in the absence of mannose 
6-phosphate. The final washing solution of saponin- 
treated TMF before extraction of ASE was also sub- 
jected to the same binding assay procedure. Finally the 
following calculation was performed. 
Ab - sb 
corrected rate of binding = ~ 
-4, - S, 
x 100, 
Fig. 1. Percentage of bovine and human liver ASE bound 
to immobilized PMR. The ASE fraction (200 ~1) diluted 
appropriately with Tris buffer containing 0.2% BSA 
(Tris-BSA) was added to 50~1 immobilized PMR 
suspension in the presence or absence of mannose 
6-phosphate. The mixture was shaken and incubated for 
90 min at 4°C. The ASE-PMR complex was collected by 
centrifugation at 1500xg for 10 min and the pellet 
washed 4 times with Tris-BSA. Finally the pellet was 
suspended in 40~1 of 0.2 M citrate/O.2 M NaCl (pH 4.5), 
incubated at 37°C for 30 min, and centrifuged. Ac- 
tivities of lysosomal enzymes were assayed in the super- 
where A, = the enzyme activity added to the immobil- 
ized PMR in the ASE fraction, At, = the enzyme activity 
bound, S, = the enzyme activity added to the im- 
mobilized PMR in the final washing solution of the 
saponin-treated TMF, and Sb = the enzyme activity 
bound. Each value represents the mean of 2 or 3 separate 
experiments. The corrected values of added and bound 
enzymes are as follows. (A) Bovine liver: (1) (Y- 
glucosidase, 29 and 2.8 mu; (2) fl-glucosidase, 110 and 
0 mu; (3) cu-galactosidase, 13 and 0.7 mu; (4) ,&- 
galactosidase, 67 and 11 mu; (5) cY-fucosidase, 140 and 
60 mu; (6) a-mannosidase, 20 and 16 mu; (7) ,& 
glucuronidase, 24 and 20 mu; (8) N-acetyl-fi- 
glucosaminidase, 360 and 220 mu. (B) Human control 
liver: (1) cY-glucosidase, 18 and 0.3 mu; (7) fl- 
glucuronidase, 31 and 24 mu; (8) N-acetyl-fi-glucos- 
aminidase, 184 and 90 mu. I-cell disease liver: (7) fl- 
glucuronidase, 15 and 0 mu; (8) N-acetyl-~-glucosamini- 
dase, 200 and 0 mu. Specific activities (unit/mg protein) 
of I-cell disease and control ASE fractions are 6.4 and 
5.1 for ,&glucuronidase, and 44 and 51 for N-acetyl-fi- 
glucosaminidase, respectively. 
Fig.2. Displacement of N-acetyl-/3-glucosaminidase in 
saponin-treated TMF by various sugars. This saponin- 
treated TMF was prepared from control (open bars) and 
I-cell disease liver (hatched bars), and washed repeatedly 
with 50 mM Tris-HCI buffer (pH 7.0) containing 0.25 M 
sucrose and 0.5% saponin. The washed TMF was 
suspended and incubated for 6 h at 4°C in 8 ml of the 
buffer containing various sugars or the buffer alone. 
The suspension was centrifuged and the enzyme activity 
in the supernatant was assayed. The amount of the en- 
zyme released in the absence of the sugar was subtracted 
from that in the presence of the sugar. Each value 
represents the mean of 2 separate experiments. 
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mannosidase. Other sugars were less effective or 
not effective. The following amounts of dissocia- 
tion were observed with 3 different sugars tested; 
30% for P-glucuronidase, 21% for cu-fucosidase 
and 21% for N-acetyl-P-glucosaminidase with 50 
mM mannose; 24% for N-acetyl-fl-glucosamini- 
dase and 29% for cy-mannosidase with 50 mM 
fucose; 23% for fl-glucuronidase with 50 mM 
galactose. 
The amounts of N-acetyl-fl-glucosaminidase 
released by various sugars from the saponin- 
treated human liver TMF are shown in fig.2. In the 
control liver 10 mM mannose 6-phosphate 
dissociated the largest amount of the enzyme ac- 
tivity (71% of ASE) from the membrane prepara- 
tion. The dissociation was lower with other sugars: 
14% with 10 mM galactose, 10% with 50 mM 
mannose and 7% with 50 mM fucose. In contrast, 
there was little dissociation with mannose 
6-phosphate in the I-cell disease liver: 3.4% at 10 
mM and 19% at 50 mM. Instead, 50 mM fucose 
was the most effective (56%), followed by 50 mM 
mannose (40%) and 50 mM N-acetyl-& 
glucosamine (27%). 
4. DISCUSSION 
Lysosomal enzyme proteins are considered to be 
sorted out by specific receptors after de novo syn- 
thesis, and transported to lysosomes. The PMR- 
mediated transport system has been recognized as 
one of these systems in human fibroblasts. It is 
highly likely that the ASE fraction in our study 
contained mainly these intermediate enzymes, as 
enzymes were extracted by treatment under acidic 
conditions from the membrane fraction. Mature 
enzymes in lysosomes must have been released by 
the detergent, and those tightly bound to 
lysosomal membranes in the acidic environment in 
vivo could not be solubilized further by the pro- 
cedure of acid extraction. It was demonstrated that 
the bovine liver PMR had a high affinity to 
u-mannosidase and ,8-glucuronidase in bovine 
liver, and might be the major transporter of these 
2 enzymes. Other enzymes were not or only partial- 
ly bound to the PMR. This result indicated that 
other PMR components [12,13] or other recogni- 
tion systems were also working for the transport of 
many lysosomal enzymes. 
PMR also seems to mediate the intracellular 
transport of newly synthesized lysosomal enzymes 
in human liver [IO]. In some enzymes examined, 
the pattern of binding to the bovine PMR was 
similar to that in bovine liver. Consequently, it can 
be concluded that the PMR system functions as a 
major transporter for fl-glucuronidase in humans 
as well as in bovines. Other recognition markers 
may exist for other enzymes. There must be 
another transport pathway in humans for targeting 
of P-glucuronidase and N-acetyl-&glucosamini- 
dase, since activities of these enzymes were normal 
in the ASE fraction of the liver from a patient with 
I-cell disease in spite of deficient binding to PMR. 
@Glucosidase is also expected to be associated 
with a recognition system other than the PMR 
pathway because this enzyme in the ASE fraction 
of bovine liver did not bind PMR and its activity 
was normal in I-cell disease fibroblasts in humans 
[14], and because no phosphate was shown in the 
molecule of human placental &glucocerebrosidase 
1151. 
What is the molecular structure of the alternate 
pathway? Some mammalian lectins (sugar-binding 
proteins) may act as receptors for processing and 
sorting of carbohydrate chains in glycoprotein 
molecules [16]. Our data indicated that several en- 
zymes were associated with the TMF preparation 
in bovine liver, and strongly dependent upon the 
mannose 6-phosphate recognition system, with the 
exception of ,&glucosidase. Some enzymes were 
released from TMF by mannose, fucose and galac- 
tose. Binding proteins specific to these sugars may 
exist and participate in the processing and the in- 
tracellular transport of lysosomal enzymes. 
This study has provided a definite clue to the 
molecular basis of the alternate pathway. In this 
experiment dissociation of N-acetyl-&glucosamini- 
dase from TMF was different between I-cell 
disease and control livers. This enzyme in ASE 
from the I-cell disease liver did not bind PMR, and 
the dissociation occurred in the presence of fucose, 
mannose and JV-acetyl-D-glucosamine, but little in 
the presence of mannose 6-phosphate. Probably 
N-acetyl-&glucosaminidase is bound mostly to 
PMR under physiological conditions, but in I-cell 
disease it may be sorted and transported as a 
glycoprotein with complex-type oligosaccharides, 
by other binding proteins, such as fucose-binding 
protein or mannose(N-acetyl-D-glucosamine- 
binding protein [ 16,171. Fucose is also known to 
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exist in high mannose type oligosaccharides [ 181. 
Fucose, mannose and galactose were effective in 
releasing N-acetyl-fl-glucosaminidase to some ex- 
tent in the control liver. These sugars may function 
as recognition markers for the processing of 
oligosaccharides and for the intracellular transport 
of this enzyme, especially when the phosphate 
marker is deficient in the ligand molecule as 
observed in l-cell disease [ 191. A processing and 
transport system not known to us at present could 
have been newly established in this disease under 
collaboration of binding proteins different from 
the PMR system. Finally the possibility cannot be 
ruled out that PMR itself recognizes molecular 
markers other than mannose 6-phosphate. 
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